Artificial intelligence-enhanced risk stratification of cancer therapeutics-related cardiac dysfunction using electrocardiographic images.
Evangelos K OikonomouVeer SanghaLovedeep Singh DhingraArya AminorroayaAndreas CoppiHarlan M KrumholzLauren A BaldassarreRohan KheraPublished in: medRxiv : the preprint server for health sciences (2024)
AI applied to baseline ECG images can stratify the risk of CTRCD associated with anthracycline or trastuzumab exposure.
Keyphrases
- artificial intelligence
- deep learning
- convolutional neural network
- big data
- left ventricular
- machine learning
- papillary thyroid
- optical coherence tomography
- squamous cell
- oxidative stress
- small molecule
- epidermal growth factor receptor
- heart rate
- heart rate variability
- heart failure
- squamous cell carcinoma
- left atrial
- childhood cancer
- young adults
- atrial fibrillation
- catheter ablation